Myriad Genetics, Inc. (NASDAQ:MYGN)

CAPS Rating: 5 out of 5

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

Recs

0
Player Avatar sellerorbuyer (< 20) Submitted: 1/14/2011 10:44:39 AM : Underperform Start Price: $21.58 MYGN Score: -15.66

so much competitors

Report this Post Reply

Featured Broker Partners


Advertisement